Avalo Therapeutics AVTX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avalo Therapeutics's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avalo Therapeutics's common stock, shares issued (in shares)?
- Avalo Therapeutics (AVTX) reported common stock, shares issued (in shares) of $24.64M in Q1 2026.
- How has Avalo Therapeutics's common stock, shares issued (in shares) changed year-over-year?
- Avalo Therapeutics's common stock, shares issued (in shares) increased by 127.5% year-over-year, from $10.83M to $24.64M.
- What is the long-term trend for Avalo Therapeutics's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Avalo Therapeutics's common stock, shares issued (in shares) has grown at a -24.4% compound annual growth rate (CAGR), from $75M to $18.51M.